News about

Laos-based BioSpring constructs Phase 1 of its manufacturing unit

Laos-based BioSpring constructs Phase 1 of its manufacturing unit

The delivery of the manufacturing unit is constructed according to the ICH(1)-GMP(2) standard

| 19/08/2022 | By 1003

Cleanroom tech market size to hit $11.46 bn by 2030: Growth Plus Reports

Cleanroom tech market size to hit $11.46 bn by 2030: Growth Plus Reports

North America dominates the global market with the largest revenue share

| 18/08/2022 | By 978

India's pharma exports rise by 8% in Q1 to $6.26 Bn

India's pharma exports rise by 8% in Q1 to $6.26 Bn

Pharma exports are expected to return to normal once the Russia-Ukraine war improves

| 18/08/2022 | By 795

Moderna to set up mRNA vaccine manufacturing facility in Melbourne

Moderna to set up mRNA vaccine manufacturing facility in Melbourne

The project will be based at one of Australia's largest universities, Monash, and will produce 100 million vaccine doses a year for COVID-19, influenza and other diseases<br />

| 17/08/2022 | By 1085

Concord Biotech files DRHP for IPO

Concord Biotech files DRHP for IPO

Concord Biotech is the leading global developer and manufacturer of select fermentation-based APIs across immunosuppressants and oncology

| 16/08/2022 | By 1168

BAL Pharma posts Rs 700.71 M revenue for Q1FY23

BAL Pharma posts Rs 700.71 M revenue for Q1FY23

Revenue was impacted by macro and uncontrolled factors led by geopolitical concerns, external market turmoil and certain other unavoidable market factors

| 16/08/2022 | By 900

Pisgah Labs to invest $55M in North Carolina facility

Pisgah Labs to invest $55M in North Carolina facility

The company is a subsidiary of India-based Ipca Laboratories

| 12/08/2022 | By 911

PCI Pharma to expand operations at Welsh site

PCI Pharma to expand operations at Welsh site

The manufacturing operations will be upgraded as part of the company’s push into targeted oncology therapies

| 12/08/2022 | By 1008

China API plant banned by FDA for having no quality control in place

China API plant banned by FDA for having no quality control in place

The batch testing that was performed was done over and over again, and only some of the results were recorded
<br />

| 11/08/2022 | By 653

Strides Pharma successfully completes US FDA inspection at Singapore facility

Strides Pharma successfully completes US FDA inspection at Singapore facility

The inspection was completed successfully with Zero 483 observations

| 11/08/2022 | By 1185

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members